89 results about "Curative treatment" patented technology

This invention provides a method and system for the curative treatment of obesity. A first aspect of this invention is that it enables identification of the nerves responsible for the relaxation of the stomach muscles that occurs prior to and during eating. A second aspect of the invention is that it allows the physician to identify focal nerve sites in the stomach and upper duodenum that are associated with producing sensations of hunger and satiety. Nervous transmission from these sites can be modulated or blocked all together so as to minimize the sensation of hunger. A third aspect of this invention is that allows a physician to shrink selected portions of the innermost oblique muscle and middle circular muscle layers of the stomach. This can be performed in a physician's office using local anesthesia. Shrinkage of these muscles produces a feeling of satiety that enhances the patient's efforts to restrict his caloric intake.

Patient support pads that form a part of conventional surgical tables are removed and replaced with pads that provide three dimensional volumetric pressure redistribution. The pads are releasably secured in overlying relation to conventional frame cushions that overlie the frame of a surgical table. Three pads are provided, one each for the head, torso, and foot section of the table so that the articulation of the table is not compromised by the pads. The pads not only prevent or inhibit the formation of decubitus ulcers during surgery but also provide therapeutic, curative treatment of the patient's dermis and epidermis by redistributing pressure without distorting or compressing soft tissue. A dual hose bifurcated manifold system connects each inflated pad to its contiguous inflated pad so that pressure applied in any one section of the surface is transmitted and redistributed over all of the inflated pads.

Provided are uses of erythropoietin, or a derivative or functional analogue thereof, for the production of a medicament for the preventive or curative treatment of patients suffering from, or at risk of suffering from, cardiac failure.

The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.

The present application relates to a sub-region of a Plasmodium protein, with improved vaccine potential, and to medical uses thereof, notably for treatment or diagnosis of malaria. The present invention notably provides unstructured or unfolded polypeptides deriving from the PFF0165c protein of P. falciparum 3D7. The polypeptides of the invention have a high antigenicity, a high immunogenicity, have a high parasite-killing activity in the ADCI assay, and are strongly associated with clinical protection against malaria, and. The present invention thereby provides a vaccine for the palliative and / or curative treatment of malaria, which is specifically intended for infants, toddlers, children under the age of 5, pregnant women.

The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the prevention and curative treatment of an inflammatory pulmonary disease.

The invention provides a Chinese traditional medicine external use hypurgia preparation for resisting bacteria and relieving itching and pertains to the technical field of Chinese traditional preparation, which is characterized in that the preparation is made by the following material drugs, and each dosage includes: 72-78g of moxa leaf, 77-83g of perilla leaf, 42-48g of senecio scandens, 17-23g of dry ginger, 32-38g of andrographis paniculata and 67-73g of motherwort. Moxa leaf, perilla leaf, senecio scandens, dry ginger, andrographis paniculata and motherwort are taken as the material drugs for preparing the Chinese traditional medicine external use hypurgia preparation for resisting bacteria and relieving itching, which is decocted by water for soaking and washing and have better effect if drugs are used together. By using the Chinese traditional medicine, the period of curative treatment is short, skin exuviation and allergy can not be caused, dermatophytosis, miliaria and prurtus can be cured radically and can not recur, and the curative effect is outstanding. And the Chinese traditional medicine can not stimulate human body and has not side effect, and can be used as a hypurgia preparation of lavipeditum and bath for soaking and washing.

The present invention pertains to the use of subunits and oligomers of collectins and / or ficolins, such as mannan-binding lectin (MBL) in prophylactic and / or curative treatment of Severe Acute Respiratory Syndrome (SARS) in an individual.

The present invention pertains to the use of subunits and oligomers of mannan- binding lectin (MBL) in prophylactic and / or curative treatment of an immunocompromised individual such as subjects suffering from solid tumors or haematological cancers. Solid tumors include such as female cancers, male cancers, cancers of the respiratory system, cancers of the gastro intestinal system, the renal system and further subjects suffering from thyroid cancer and melanomas. Haematological cancers include leukaemia, lymphoma and myeloma. The immunocompromised condition of the individual may be due to a cancer disease as mentioned herein or the treatment of said cancer disease.

The invention relates to a novel medical diagnostic method and treatment in conjunction with depression-inducing genes which are stimulated in particular by interferon. The invention relates in particular to the use of at least one nucleic acid molecule which induces depression and / or is associated with depression, in particular a gene and / or the DNA sequence thereof and / or the RNA sequence associated therewith, and / or a (poly)peptide encoded by the nucleic acid, for finding and / or providing a diagnostic method for detecting depression, or a medicament for the preventive and / or curative treatment of depression, and / or for determining the risk of developing depression, and / or for predicting the individual effects and / or side-effects of medicaments, in particular for treatment with interferon (for example, for the treatment of hepatitis).